Long-term Follow-up of 84 Patients With Giant Prolactinomas—A Swedish Nationwide Study

Abstract

DAs effectively reduced PRL and tumor size, but approximately 1 patient out of 4 needed multimodal treatment. Our results suggest that the response to DA after 1 year is useful for identifying patients who need more careful monitoring and, in some cases, additional treatment.